Date: 2013-04-29
Type of information: Plant acquisition
Compound: manufacturing plant in Rochester
Company: UCB (Belgium) Unither Pharmaceuticals (France)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On May 29, 2013, UCB has agreed with Unither Pharmaceuticals, a leading pharmaceutical manufacturer, that Unither will acquire UCB’s manufacturing plant in Rochester, New York. The agreement is part of UCB’s strategy to optimize its manufacturing network in line with the evolution of its portfolio. The transaction also includes a six-year supply agreement between UCB and Uither and UCB Rochester’s approximately 250 employees and 50 temporary staff will all be offered employment opportunities with Unither.
Financial terms: The financial details of the agreement were not disclosed.
Latest news:
